NCT06552117View on ClinicalTrials.gov

ElastoMRI Evaluation of Hepatic Metastases in Colorectal Cancer ( MetaIRM)

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 10, 2024

Primary Completion Date

October 30, 2026

Study Completion Date

June 30, 2027

Conditions
Colorectal Cancer With Liver Metastases
Interventions
OTHER

an elastoMRI sequence

Addition of an MRI elasto sequence performed during MRI performed as part of the treatment

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06552117 - ElastoMRI Evaluation of Hepatic Metastases in Colorectal Cancer ( MetaIRM) | Biotech Hunter | Biotech Hunter